Latest Australia News

Zimi has moved its next-generation Matter smart-home range closer to certification and production, while securing access to more than 10,000 retail outlets through Directed. But the company ended September with $344,000 in cash after burning $714,000 on operations, leaving further funding firmly in the frame.

4DMedical reported a record first quarter, with scan volumes up 61% to 119,672 and unaudited operating revenue rising 66% to $2.3 million. New contracts across the US, Germany and Australia broaden the commercial story, while $242.8 million in cash gives the company room to keep investing.

Nico Resources has completed about 70% of a 6,000-metre infill drilling program at its Wingellina nickel-cobalt project, with initial assays expected in November. The technical progress comes as nickel and cobalt prices weaken and a proposed downstream partnership remains non-binding.

Metal Bank has shifted its first-production focus to the larger Homestead deposit in Western Australia, targeting production in 2027 as mining approvals and technical studies advance. The company also raised a further $752,400 after quarter end, but the path from resource to mine still depends on drilling, metallurgy, approvals and funding.

Archer Materials has moved its IonQ relationship into early commercial activity and advanced its Biochip towards external testing, but its graphene spin qubit demonstration is taking longer than expected. The company ended September with $A13.0 million in cash and an estimated 4.68 quarters of funding at its quarterly operating burn.

SHAPE Australia has lifted FY27 project wins above $1.4 billion after securing an approximately $800 million DigiCo data centre contract, with the project expected to add about $200 million of revenue in each of FY27 and FY28. The award comes alongside stronger modular revenue, a new Western Australian facility and a quarter-end backlog up 21%.

Big River Industries has carried its FY26 recovery into the new financial year, reporting 10.5% first-quarter revenue growth and a further lift in gross margin. The building-products group says its growth initiatives support above-market expansion, while a strategic review remains unresolved.

Sea Forest lifted first-quarter revenue 67% to A$3.4 million and generated a small operating cash inflow as it transitioned to a new distribution arrangement with Teys Australia. The agreement carries an indicative target of 480,000 cattle by June 2027, but the volume is not guaranteed and remains subject to implementation conditions.

Ore Resources has converted its Miriam drilling campaign into a 153,200-ounce JORC Mineral Resource, with most ounces shallow and Forrest still open along strike and at depth. A separate conceptual Exploration Target points to a further 200,000 to 400,000 ounces, but remains unconverted exploration potential.

LTR Pharma has moved ROXUS from signed US commercial agreements to its first fulfilled patient-specific prescriptions, while SPONTAN’s final Phase II report completes the pharmacokinetic dataset agreed with the FDA. The company ended September with A$18.2 million in cash and no debt.

Neurotech International has dosed the first patient in its pivotal Phase 3 trial of NTI164, with all six Australian sites now active and up to 200 children planned for enrolment. The milestone sits alongside FDA clearance and fresh funding, but quarter-end cash covered only 1.24 quarters of historical operating outflows.

Veris is using its FY26 results and first-quarter trading update to make the case that its transformation from surveyor to digital and spatial advisory firm is gaining traction. Revenue and underlying EBITDA rose, while the planned Aurecon acquisition adds a near-term test of whether the strategy can convert into stronger earnings.